Andrew Regan - 22 Oct 2026 Form 4 Insider Report for CDT Equity Inc. (CDT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Oct 2026, 16:33:12 UTC
Prior SEC filing
27 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Regan
Filing notes and source

Key filing fact

Andrew Regan filed Form 4 for CDT Equity Inc. (CDT) on 27 Oct 2026.

Key facts

  • This page summarizes Andrew Regan's Form 4 filing for CDT Equity Inc. (CDT).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 27 Oct 2026, 16:33.

Change

  • Previous filing in this sequence was filed on 27 Oct 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0001991325 Primary reporting owner

Regan Andrew

Relationship
10%+ Owner
Address
4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES
Signature
/s/ Andrew Regan
Signature date
27 Oct 2026
CIK 0001990829

Corvus Capital Ltd.

Relationship
10%+ Owner
Address
FLOOR 2, WILLOW HOUSE, CRICKET SQUARE, P.O. BOX 709, GRAND CAYMAN, CAYMAN ISLANDS
Signature
CORVUS CAPITAL LTD. /s/ Andrew Regan, Chief Executive Officer
Signature date
27 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDT transaction

Common Stock

Other

Transaction value
Shares
+499,616
Change %
+24980800%
Price
Shares after
499,618
Date
23 Oct 2026
Ownership
Direct
Footnotes
F1
CDT transaction

Common Stock

Other

Transaction value
Shares
+499,616
Change %
+24980800%
Price
Shares after
499,618
Date
23 Oct 2026
Ownership
Direct
Footnotes
F1
CDT transaction

Common Stock

Other

Transaction value
Shares
+1,347,616
Change %
+44920533%
Price
Shares after
1,347,619
Date
22 Oct 2026
Ownership
By Manoira Corporation
Footnotes
F2, F4
CDT transaction

Common Stock

Other

Transaction value
Shares
+1,347,616
Change %
+44920533%
Price
Shares after
1,347,619
Date
22 Oct 2026
Ownership
By Manoira Corporation
Footnotes
F2, F4
CDT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
217,461
Date
22 Oct 2026
Ownership
By Corvus Capital Ltd
Footnotes
F3, F4
CDT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
217,461
Date
22 Oct 2026
Ownership
By Corvus Capital Ltd
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On August 31, 2026, in connection with his resignation as Chief Executive Officer and a director of CDT Equity Inc. (the "Issuer") effective as of that date, Dr. Regan became eligible to receive $300,000 in severance payments. On October 23, 2026, at the Issuer's request, $65,000 of the remaining severance payment was converted into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"), at a conversion price of $0.1301 per share, and Dr. Regan received 499,616 shares of Common Stock upon such conversion.

Footnote F2

These shares of Common Stock are owned of record by Manoira Corporation ("Manoira"). On October 22, 2026, Manoira entered into an Evaluation Agreement with the Issuer (the "Evaluation Agreement"), pursuant to which the Issuer agreed to pay Manoira a one time fee of $195,000 for the services to be provided by Manoira thereunder. On October 22, 2026, the Issuer issued to Manoira 1,347,616 shares of Common Stock in full satisfaction of the fee due to Manoira, at a price of $0.1447 per share.

Footnote F3

These shares of Common Stock are owned of record by Corvus Capital Limited ("Corvus").

Footnote F4

Corvus owns 87.0% of the outstanding equity interests of Manoira and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira. Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, except to the extent of its or his pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .